Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile

Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile

US Patent 9987227 · Granted Jun 5, 2018

Estimated economic value: $672,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Liposomal ciprofloxacin formulations with activity against non-tuberculous mycob2021
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycob2021
Concentrated, inhalable ciprofloxacin formulation2021
Concentrated, inhalable ciprofloxacin formulation2019
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycob2019
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycob2019
Liposomal formulations that form drug nanocrystals after freeze-thaw2018
Liposomal formulations that form drug nanocrystals after freeze-thaw2018
Diagnosis of entry of gastrointestinal contents into respiratory tract of humans2018
Liposomal ciprofloxacin formulations with encapsulated ciprofloxacin nanocrystal2017
Liposomal ciprofloxacin formulations with encapsulated ciprofloxacin nanocrystal2017
Diagnosis and treatment methods for entry of gastrointestinal contents into resp2017